
New research suggests that in the era of disease-modifying therapies, women with multiple sclerosis face no heightened risks of relapse after pregnancy.

New research suggests that in the era of disease-modifying therapies, women with multiple sclerosis face no heightened risks of relapse after pregnancy.

A prospective study of over 500 patients found those with influenza A had more severe symptoms and slower recovery than those with influenza B.

Researchers say a new challenge virus didn’t lead to influenza in as many patients as expected, but it will still yield valuable insights as researchers push to develop a universal flu vaccine.

A study suggests individuals who received egg-based flu vaccines had less protection against circulating strains of influenza than those with cell-based vaccines in the 2017-2018 season.

By identifying epitopes that are common to all types of the flu, researchers believe they may have created a pathway to a universal flu vaccine.

New research based on 8 flu seasons’ worth of data supports the early use of oseltamivir, particularly in cases of A(H3N2) influenza.

As people age, their B cells become less adaptive, leaving them more susceptible to the flu.

Each flu season, the race is on to determine how well the flu vaccine is working. But researchers caution that many of the studies used to calculate effectiveness have potential pitfalls.

New research shows women who are pregnant face a higher risk of ending up in the hospital, regardless of pregnancy stage.

A new CDC study found the flu vaccine was 38% effective last year, but it also stopped more than 100,000 hospitalizations.

Patients with influenza-like illness face a higher risk of stroke up to a year after infection.

Flu vaccination reduced influenza-related hospitalizations by 38% among patients with COPD.

A new study confirmed that HIV infection significantly increases the risk of death for patients with hepatocellular carcinoma.

A new study found that deaths in the end-stage renal disease population correlated with seasonal trends in flu and flu-like illnesses.

A new study finds patients who have high, real, or perceived risk of HIV are more likely to accept PrEP when they have access to it.

Parents hoping to spare their children from colds and the flu follow scientific recommendations in high numbers, but they are also susceptible to unscientific “folklore.”

Investigators say they’ve developed a more accurate model for tracking and predicting the spread of influenza.

New research based on more than a quarter-million patient records shows vaccinating patients against the flu while hospitalized is safe.

A new review shows transgender women face higher HIV rates than transgender men, but also finds a relative lack of data about transmen.

New research finds participants don’t always accurately report—or know—their HIV status when enrolling in studies.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

A new analysis finds racial and ethnic disparities vary significantly from state to state when it comes to sexually transmitted infection rates among men who have sex with men.

In theory, the combination of ART and PrEP would be enough to virtually eradicate HIV. In the real world, they’re falling well short.

New research confirms the apparent link between schistosomiasis and risk of HIV transmission and acquisition.

Researchers studied patients with hepatitis C in order to find out the relationship between immune activation and chronic fatigue.

A Canadian study finds patients like using an app meant to work alongside at-home HIV tests and ensure patients are quickly linked with care.

New research finds foreign-born black women aren’t benefiting from public health advances in HIV at the same rates.

New research helps explain why young gay black men have much higher rates of HIV despite also having much lower rates of risky behavior.

After successful trials in animal models, researchers say they will soon launch clinical trials of an eye drop to treat age-related macular degeneration.

New research shows the majority of young people get HCV through drug use, but also finds liver disease progresses at the same pace regardless of age at diagnosis.